Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Oct;142(4):660-8.
doi: 10.1016/j.ajo.2006.05.061.

Antivascular endothelial growth factor agents and their development: therapeutic implications in ocular diseases

Peter K Kaiser  1
Affiliations

Antivascular endothelial growth factor agents and their development: therapeutic implications in ocular diseases

Peter K Kaiser. Am J Ophthalmol. 2006 Oct.

Abstract

Purpose: To provide an overview of angiogenesis and vascular endothelial growth factor (VEGF) and discusses the development approach, safety, and efficacy results of current and emerging anti-VEGF therapies for ocular diseases.

Design: Analysis of literature and current clinical trials of antiangiogenic agents for age-related macular degeneration (AMD).

Methods: Literature review.

Results: There are several novel antiangiogenic molecules that target vascular endothelial growth factor and are being used in the management of AMD. Large scale, Phase III trials have shown promising results in improving vision in this devastating disease.

Conclusions: Therapies that target VEGF have shown tremendous promise as treatments for AMD.

PubMed Disclaimer

Publication types

MeSH terms

LinkOut - more resources